350 likes | 473 Views
ZW 09-11 GMP Lab for production of PET tracers for clinical and translational research. Luc Mortelmans, Guy Bormans, Koen Van Laere, Christophe Deroose, Alfons Verbruggen, Johan Nuyts. positron emission tomography (PET).
E N D
ZW 09-11GMP Lab for production of PET tracers for clinical and translational research Luc Mortelmans, Guy Bormans, Koen Van Laere, Christophe Deroose, Alfons Verbruggen, Johan Nuyts
positron emission tomography (PET) • Tracks molecules in the body by external detection of gamma rays emitted during decay of short-livedpositron emittingradionuclides 3. Images representing tracer distribution are reconstructed 1. Tracer injection + distribution throughout the body 2. External detection of gamma rays (PET camera)
positron emission tomography (PET) Modelling of kinetic analysis of PET data provides parametric maps e.g. in vivo receptor occupancy Time-activity curves Kinetic modelling Binding potential Bmax/Kd Plasma input curve Radiometabolite quantification
PET tracer production: layout Radionuclide production Cyclotron irradiation (fluorine-18, carbon-11) Generator (gallium-68) Radiosynthesis incorporation of radionuclide in target molecule Purification and formulation Prepar. HPLC, sterile membrane filtration QC HPLC, GC, pH, sterility, pyrogens …
PET tracer production: a race against time Cyclotron production Purification & formulation Scanning & Sample processing radiosynthesis QC
WhycGMPfor PET tracers? Radiopharmaceuticalforhumanuse Intravenousadministration For clinical trials: cGMPrequired
PET tracers for clinical research and cGMP: legal issues Belgian Royal Decree May 7th 2004 experiments on the human person CHAPTER XIII. – § 3 a …in the case of investigational medicinal products manufactured in Belgium, that each batch of medicinal products has been manufactured and checked in accordance with the principles and guidelines for good manufacturing practices EC Directives 2003/94/EC principles and guidelines of good manufacturing practice of medicinal products and investigational medicinal products for human use
PET tracers for clinical research and cGMP: legal issues Eudralex volume 4: Good manufacturing practices
Requestedinfrastructure Total budget : €2,733,840 personnel € 238,000 maintenance contracts € 115,000 quality controlequipment € 457,000 hot cells € 850,000 infrastructure/equipment € 2,380,000 Radiolabelling modules € 1,071,000
Proposedfinancing Total support from companies:€ 750,000 (27%) Siemens € 150,000 GE € 150,000 Johnson&Johnson € 200,000 Merck € 250,000 Hercules foundation € 1,984,000
Project fits in the strategy of K.U. Leuven • MoSAIC: “Molecular Small Animal Imaging Centre” • Radiopharmacy lab • Investment in building GMP lab • State of the art clinical pharmacology lab • Medical Image Research Center (MIRC) • Flanders “PET net” (network)
6 synthesishotcells, 1 dispensinghotcellforcontract research New building level 01 FDG + Contract research 4 synthesishotcells, 1 dispensinghotcellforFDG
University Hospital Leuven Nuclear Medicine Nuclear Medicine Cyclotron MoSAIC Radiopharmacy Lab
“MIRACLE” (Molecular Imaging Research & Application Center Leuven) From bench to bedside
University Hospital LeuvenNuclear Medicine Antwerpen, VUB, KUL, RUG, UCL, ULG, ULB (UNIV – 7) Hasselt, Charlerloi, Kortrijk, Bodet, Antwerpen, Mont-Godinne (NIET-UNIV – 6)
Onco-imaging clinic & research Oncology Clinical research Medical Physics • A) Diagnosis • Lungtumours • GI tumours • Lymphoma • Sarcoma (GIST) • Breasttumours • Response evaluation • earlyclinical trials • B) Therapy Reconstruction Kinetic modelling Data-analysis Image registration PET microPET SPECT microSPECT Bioluminiscense MRI microMRI Neurology & psychiatry Radiology Gene expression Infection and inflammation Cardiology Radiopharmaceutical chemistry PET 18F labeling 11C labeling SPECT 99mTc labeling 123I labeling
Nuclear neuro-imaging research Medical Physics Clinical research NeuroImaging Oncology Reconstruction • Neurology & psychiatry • Movement disorders • Epilepsy • Dementia • Brain Tumours • Eating disorders • Anxiety and mood disorders Kinetic modelling Data-analysis Image registration PET microPET SPECT microSPECT Bioluminiscentie MRI microMRI Radiology Gene expression Infection and inflammation Cardiology Radiopharmaceutical chemistry PET 18F labeling 11C labeling SPECT 99mTc labeling 123I labeling
ExperimentalPET-CT Biograph16-HiRez (contract research 2005)
MIRACLE : multidisciplinary platform Radiology Clinical nuclear medicine Medical Physics • Clinical Pharmacology • Recruitment (esp. HV) • Screening • Drug admin • PK sampling • ... Oncology Neurology/psychiatry Reconstruction Image registration Cardiology Infection-inflammation Data-analysis Stem cell research Kinetic modelling Gene expression Clinical Divisions - Patient recruitment PET 18F 11C SPECT 99mTc 123I Radiopharmaceutical chemistry
Position & Role of MoSAIC Life sciences imaging clinical Improved diagnosis/ therapy preclinical development Omics clinical research ‘basic’ research drug review/ market MoSAIC Novel diagnostic & therapeutic strategies Improved insights & novel hypotheses IMAGING SOLUTIONS core partners peripheral partners
MoSAIC multimodality imaging facility (2007) Dedicated small animal imaging equipment CT US PET SPECT Clinical imaging equipment adapted to small animal scanning: BLI MRI
positron emission tomography (PET) • Translational molecular imaging technique microPET scanner clinical PET scanner imaging of dopamine transporter Rat model of Parkinson’s disease normal PatientwithPD
PET in drug development $ 800 MM - $1.6BN $$$ Regulatory Approval Laboratory Clinic Research Clinical Trials Accept or Reject a Candidate or Hypothesis Toxicology Refine Leads Find Leads Identify Targets Development 1 3 5 7 Time (Years) Slide courtesy of R Hargreaves, MSD
PET in drug development PET provides -early clinical target validation -early clinical target occupancy data as a funtion of dose as a function of time p.i. development of PET probes for new targets in parallel to drug development by all major pharmaceutical companies (MSD, Novartis, J&J, SKB, Roche,…)
PET tracers for clinical research and cGMP: legal issues Eudralex volume 4: Good Manufacturing Practices Aseptic activities Class “A“air Production cell class “C” air
Center for ClinicalPharmacologyClinical Research Unit (1) Facilities hotel accommodation: 20 beds for overnight stay sanitary facilities (3 showers) 2 recreational areas (internet access, TV, video, …) research laboratories (4 laboratories; 2 temperature controlled) laboratory for sample processing medication room secretary and offices meeting room / monitoring office archive
Center for ClinicalPharmacologyClinical Research Unit: study types 1998-2007
MoSAICMolecular SmallAnimal Imaging Center A: µPET B: µCT C: µUS D:µSPECT E: µMRI F: BLI C Animal modelsof human disease D 380 m² Imaging 320 m² Support
3 synthesishotcells 1 dispensing hotcell for FDG Upgrade level 0: FDG (temporarily) + research 10 synthesishotcellsfor research 1 gloveboxfor dispensing 1 LAF-cabinet Sas